Scale -


  • Ebitda is 8.24 Rs Cr; Annual Growth is 42 %; Continuous Growth over 3 years
  • PBT is 1.42 Rs Cr; Annual Growth is 82 %; Continuous Growth over 3 years
  • PAT is 5.81 Rs Cr; Annual Growth is 92 %; Continuous Growth over 3 years
  • Revenue is 85.74 Rs Cr; Continuous Growth over 3 years
  • Quarterly Revenue is 22.96 Rs Cr; Continuous Growth over 3 Quarters

Profitability -


  • PBDIT Margin is 9.59 %; Annual Growth is 36 %; Continuous Growth over 3 years
  • PAT Margin is 6.77 %; Annual Growth is 85 %; Continuous Growth over 3 years
  • Quarterly Profit margin is 6 %; Continuous Growth over 3 Quarters

Return -


  • ROCE is 5.25 %; Annual Growth is 26 %; Continuous Growth over 3 years
  • ROA is 16.59 %; Annual Growth is 306 %; Continuous Growth over 3 years; in Top Quartile
  • ROE is 20.04 %; Annual Growth is 297 %; Continuous Growth over 3 years; in Top Quartile
  • Asset Turnover is 63 %; Continuous Decline over 3 years

Efficiency -


  • Operating cash flow is 9.29 Rs Cr; Annual Growth is 253 %; Continuous Growth over 3 years; in Top Quartile
  • Current Ratio is 1.72; Continuous Growth over 3 years
  • Quick Ratio is 1.21; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 8.48; in Top Quartile; 5 Year CAGR is 38 %

Solvancy -


  • Debt/Equity is 0.06; 5 Year CAGR is -37 %
  • Long term Debt is 1.19 Rs Cr; 5 Year CAGR is -40 %; Annual Growth is 815 %; Continuous Growth over 3 years
  • Total Debt is 7.28 Rs Cr; 5 Year CAGR is -26 %; Continuous Growth over 3 years
  • Contingent Liabilities is 125 Rs Cr; Annual Growth is 61 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 99 %

Quality -


  • Operating cashflow/ebitda is 113 %; Annual Growth is 149 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is -20 %
  • Operating cashflow/PAT is 160 %; Annual Growth is 84 %; Continuous Growth over 3 years; in Top Quartile
  • Change in Inventories/Total Expenses is -1 %; Annual Decline is -454 %; Continuous Decline over 3 years; in Bottom Quartile
  • Other Expenses/Total Expenses is 15 %; Annual Growth is 133 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Brooks Laboratories Limited Estimates – NSE:BROOKS
Brooks Laboratories approves demerger of manufacturing business
Brooks Laboratories Share Price rises 9.24% to Rs 70.67
Brooks Laboratories NSE:BROOKS Price Movement Clarification
Brooks Laboratories Stock Recovery and Outlook
Brooks Laboratories Upper Circuit Today: Price, Data and Peers
Brooks Laboratories (BROOKS.NS) Ticks Higher: Shares at ?55.05 as Pharma Counter Nears Resistance
Brooks Laboratories (BROOKS.NS) Slips 4.09% to ?53.52 as Stock Tests Lower Support Zone